A specific collaborative research project with Kyoto Prefectural University of Medicine on a therapy for selectively eliminating disease-associated B cells using BAR-T cells in conditions involving autoantibodies. Although the collaborative research ended due to challenges in preclinical testing, basic research will continue, with the results used in the research and development of new regenerative medicine products and other products.